The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant hormone therapy use in early-stage breast cancer patients insured by the New York State Medicaid program.
R. L. Yung
No relevant relationships to disclose
M. J. Hassett
No relevant relationships to disclose
K. Chen
No relevant relationships to disclose
F. C. Gesten
No relevant relationships to disclose
P. R. Roohan
No relevant relationships to disclose
F. P. Boscoe
No relevant relationships to disclose
A. H. Sinclair
No relevant relationships to disclose
M. J. Schymura
No relevant relationships to disclose
D. Schrag
No relevant relationships to disclose